Showing results (1731-1740 of 1,840) with videos related to
Sort By:
Pageof 184
Signal Transduction and Targeted Therapy|March 30, 2024
The two sides of chromosomal instability: drivers and brakes in cancerRendy Hosea, Sharon Hillary, Sumera Naqvi, et al.Signal Transduction and Targeted Therapy|March 11, 2024
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potentialYu-Ling Xiao, Yue Gong, Ying-Jia Qi, et al.Signal Transduction and Targeted Therapy|July 16, 2024
Exploring treatment options in cancer: Tumor treatment strategiesBeilei Liu, Hongyu Zhou, Licheng Tan, et al.Signal Transduction and Targeted Therapy|March 27, 2024
Rapid development of double-hit mRNA antibody cocktail against orthopoxvirusesHang Chi, Suo-Qun Zhao, Ru-Yi Chen, et al.Signal Transduction and Targeted Therapy|April 2, 2024
Adeno-associated virus as a delivery vector for gene therapy of human diseasesJiang-Hui Wang, Dominic J Gessler, Wei Zhan, et al.Signal Transduction and Targeted Therapy|April 7, 2024
The gasdermin family: emerging therapeutic targets in diseasesChenglong Zhu, Sheng Xu, Ruoyu Jiang, et al.Signal Transduction and Targeted Therapy|January 21, 2024
Bone-targeting engineered small extracellular vesicles carrying anti-miR-6359-CGGGAGC prevent valproic acid-induced bone lossXudong Xie, Peng Cheng, Liangcong Hu, et al.Signal Transduction and Targeted Therapy|September 8, 2024
Anti-PD-L1 antibody ASC22 in combination with a histone deacetylase inhibitor chidamide as a "shock and kill" strategy for ART-free virological control: a phase II single-arm studyLuling Wu, Zhihang Zheng, Jingna Xun, et al.Signal Transduction and Targeted Therapy|September 10, 2024
Sex difference in human diseases: mechanistic insights and clinical implicationsYuncong Shi, Jianshuai Ma, Sijin Li, et al.Signal Transduction and Targeted Therapy|August 28, 2024
Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advancesLianyu Zhao, Song Jin, Shengyao Wang, et al.Pageof 184